Holen Sie sich die Stockscreener-App
13.29
0.30%
-0.035
Schlusskurs vom Vortag:
$13.25
Offen:
$13.32
24-Stunden-Volumen:
15,081
Relative Volume:
0.05
Marktkapitalisierung:
$653.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.71%
1M Leistung:
-2.15%
6M Leistung:
+25.69%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.10
$13.57
1-Wochen-Bereich:
$12.52
$14.13
52-Wochen-Spanne:
$6.565
$17.71
Jade Biosciences Inc Stock (JBIO) Company Profile
Firmenname
Jade Biosciences Inc
Sektor
Branche
Telefon
(781) 312-3013
Adresse
221 CRESCENT ST., WALTHAM
Vergleichen Sie JBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
13.24 | 653.41M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.36 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
811.17 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.36 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.32 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-09 | Eingeleitet | BTIG Research | Buy |
| 2025-07-14 | Eingeleitet | Jefferies | Buy |
| 2025-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-05-07 | Eingeleitet | Wedbush | Outperform |
| 2025-05-05 | Eingeleitet | Stifel | Buy |
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2024-06-18 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-06-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-03-25 | Fortgesetzt | Jefferies | Buy |
| 2023-12-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-02-11 | Eingeleitet | BTIG Research | Buy |
| 2021-07-26 | Eingeleitet | Cowen | Outperform |
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform |
| 2021-07-26 | Eingeleitet | Jefferies | Buy |
| 2021-07-26 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - ulpravda.ru
Jade Biosciences (NASDAQ:JBIO) Coverage Initiated at HC Wainwright - Defense World
Why Jade Biosciences Inc. stock is popular among millennialsQuarterly Portfolio Review & Daily Growth Stock Tips - ulpravda.ru
Will Jade Biosciences Inc. stock benefit from sector rotationPortfolio Performance Summary & Stepwise Trade Signal Implementation - ulpravda.ru
How Jade Biosciences Inc. stock reacts to global recession fearsPortfolio Value Report & Short-Term Swing Trade Alerts - ulpravda.ru
Why Jade Biosciences Inc. stock remains a top recommendationMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru
H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com Canada
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq
Will Jade Biosciences Inc. stock rally after Fed decisions2026 world cup usa national team semifinals star players counter attacking odds analysis preview - ulpravda.ru
Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN
The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance
Jade Biosciences outlines 2026 clinical pipeline and milestones By Investing.com - Investing.com Nigeria
Jade Biosciences (NASDAQ:JBIO) Shares Gap DownTime to Sell? - MarketBeat
Jade Biosciences Outlines 2026 Autoimmune Pipeline Priorities - TipRanks
Jade Biosciences outlines 2026 clinical pipeline and milestones - Investing.com
Jade Biosciences Outlines Key 2026 Objectives and Strategy - GlobeNewswire
Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7%Here's Why - MarketBeat
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat
Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - MarketScreener
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Jade Biosciences files for offering of 3.2 million shares of common stock by selling stockholderSEC filing - marketscreener.com
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5%Here's What Happened - MarketBeat
What analysts say about Jade Biosciences Inc stockStock Liquidity Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Jade Biosciences Inc JBIO’s stock price gains traction on Friday - uspostnews.com
Is Jade Biosciences Inc. stock supported by strong cash flowsGap Down & Real-Time Chart Pattern Alerts - Улправда
Why Jade Biosciences Inc. stock is a value investor pickPortfolio Return Report & Accurate Intraday Trading Signals - Улправда
Is Jade Biosciences Inc. stock resilient to inflationWeekly Trade Recap & Capital Protection Trading Alerts - Улправда
Form 424B3 Jade Biosciences, Inc. - StreetInsider
Published on: 2025-12-19 20:08:24 - Улправда
Is Jade Biosciences Inc. stock a safe investment in uncertain marketsGap Up & AI Forecasted Entry/Exit Points - Улправда
How risky is Jade Biosciences Inc. stock nowMarket Trend Report & Daily Momentum Trading Reports - DonanımHaber
What analyst consensus says on Jade Biosciences Inc. stock2025 Trade Ideas & Fast Entry Momentum Alerts - Улправда
JBIO Surges Over 75% In Just Two Months On Pipeline MomentumDid You Take The Bet? - RTTNews
Latham & Watkins Advises Jade Biosciences on US$45 Million Private Placement - Legal Desire Media and Insights
Jade Biosciences prices 3.21M shares at $14.00 in private placement - MSN
Jade Biosciences secures $45 million in private placement from BB Biotech - Investing.com Nigeria
Jade Biosciences secures $45 million in private placement from BB Biotech By Investing.com - Investing.com South Africa
Jade Biosciences Says to Raise $45 Million via Private Placement of 3.2 Million Shares - marketscreener.com
Jade Biosciences announces $45 million private placement - marketscreener.com
Jade Biosciences Announces $45 Million Private Placement - GlobeNewswire
Frazier Life Sciences Management L.P. Makes New $17.70 Million Investment in Jade Biosciences, Inc. $JBIO - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Trading 7.4% HigherHere's What Happened - MarketBeat
Jade Biosciences, Inc. announced that it expects to receive $45.000004 million in funding - marketscreener.com
Jade Biosciences (JBIO): Analyst Lauds Entry into Market - Finviz
Jade Biosciences (JBIO): Analyst lauds entry into market - MSN
Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)
Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):